On this episode of the J&J Innovation Podcast, we sit down with Artie Suckow, chief scientific officer of DTx Pharma, who explains what an "oligonucleotide therapeutic" is, and how they can potentially prevent disease-causing proteins from expressing themselves. We also talk to Jeff Friedman, who details his journey from investor to chief operations officer of DTx.